Regions Financial Corp Neurocrine Biosciences Inc Transaction History

Regions Financial Corp

$13.8 Billion
Q3 2024

A detailed history of Regions Financial Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Regions Financial Corp holds 2,624 shares of NBIX stock, worth $398,375. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,624

Previous 3,167 17.15%

Holding current value

$398,375

Previous $436,000 30.73%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$114.58 - $153.15 $62,216 - $83,160	-543 Reduced 17.15%	2,624 $302,000
Q2 2024 Jul 31, 2024	SELL	$130.86 - $143.19 $2,355 - $2,577	-18 Reduced 0.57%	3,167 $436,000
Q1 2024 Apr 23, 2024	SELL	$130.4 - $143.74 $20,212 - $22,279	-155 Reduced 4.64%	3,185 $439,000
Q4 2023 Feb 06, 2024	SELL	$106.07 - $132.76 $13,258 - $16,595	-125 Reduced 3.61%	3,340 $440,000
Q3 2023 Nov 01, 2023	SELL	$94.02 - $117.1 $11,282 - $14,052	-120 Reduced 3.35%	3,465 $389,000
Q2 2023 Aug 09, 2023	SELL	$89.53 - $104.87 $6,177 - $7,236	-69 Reduced 1.89%	3,585 $338,000
Q1 2023 May 12, 2023	SELL	$94.11 - $123.02 $20,233 - $26,449	-215 Reduced 5.56%	3,654 $370,000
Q4 2022 Feb 03, 2023	SELL	$106.72 - $127.06 $5,336 - $6,353	-50 Reduced 1.28%	3,869 $462,000
Q3 2022 Nov 03, 2022	SELL	$92.03 - $107.81 $15,461 - $18,112	-168 Reduced 4.11%	3,919 $416,000
Q2 2022 Jul 25, 2022	BUY	$75.79 - $100.07 $36,682 - $48,433	484 Added 13.43%	4,087 $398,000
Q1 2022 Apr 25, 2022	BUY	$72.45 - $94.81 $63,538 - $83,148	877 Added 32.17%	3,603 $338,000
Q4 2021 Jan 31, 2022	SELL	$79.65 - $106.22 $34,568 - $46,099	-434 Reduced 13.73%	2,726 $232,000
Q3 2021 Nov 04, 2021	BUY	$86.18 - $99.03 $6,032 - $6,932	70 Added 2.27%	3,160 $303,000
Q2 2021 Jul 27, 2021	SELL	$89.43 - $102.27 $126,275 - $144,405	-1,412 Reduced 31.36%	3,090 $300,000
Q1 2021 Jun 02, 2021	BUY	$87.57 - $119.4 $5,516 - $7,522	63 Added 1.42%	4,502 $437,000
Q4 2020 Feb 05, 2021	SELL	$86.91 - $108.33 $1,564 - $1,949	-18 Reduced 0.4%	4,439 $425,000
Q3 2020 Oct 15, 2020	BUY	$96.16 - $135.15 $96 - $135	1 Added 0.02%	4,457 $429,000
Q2 2020 Jul 27, 2020	BUY	$85.09 - $130.36 $89,769 - $137,529	1,055 Added 31.02%	4,456 $544,000
Q1 2020 Apr 29, 2020	BUY	$75.11 - $113.76 $23,058 - $34,924	307 Added 9.92%	3,401 $295,000
Q4 2019 Feb 03, 2020	BUY	$86.8 - $118.57 $5,208 - $7,114	60 Added 1.98%	3,094 $333,000
Q3 2019 Oct 24, 2019	SELL	$83.82 - $101.5 $2,766 - $3,349	-33 Reduced 1.08%	3,034 $273,000
Q2 2019 Jul 19, 2019	BUY	$72.24 - $91.27 $6,501 - $8,214	90 Added 3.02%	3,067 $259,000
Q1 2019 Apr 19, 2019	BUY	$69.31 - $91.53 $47,685 - $62,972	688 Added 30.06%	2,977 $262,000
Q4 2018 Jan 28, 2019	BUY	$68.32 - $124.36 $68,661 - $124,981	1,005 Added 78.27%	2,289 $164,000
Q3 2018 Oct 22, 2018	SELL	$98.88 - $125.85 $988 - $1,258	-10 Reduced 0.77%	1,284 $158,000
Q2 2018 Jul 26, 2018	BUY	$75.3 - $105.99 $97,438 - $137,151	1,294 New	1,294 $127,000

Others Institutions Holding NBIX

# of Institutions

638

Shares Held

93.8M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.

Account

Regions Financial Corp Neurocrine Biosciences Inc Transaction History